2022
195. Reducing Time to Optimal Antimicrobial Therapy (OAT) for Bloodstream Infections (BSI) due to Gram Positive Cocci (GPC) in Chains Using Rapid Diagnostics Paired with Antimicrobial Stewardship (ASP) Efforts
K J, McSweeney T, McManus D, Davis M, Merwede J, Peaper D, Topal J. 195. Reducing Time to Optimal Antimicrobial Therapy (OAT) for Bloodstream Infections (BSI) due to Gram Positive Cocci (GPC) in Chains Using Rapid Diagnostics Paired with Antimicrobial Stewardship (ASP) Efforts. Open Forum Infectious Diseases 2022, 9: ofac492.273. PMCID: PMC9752006, DOI: 10.1093/ofid/ofac492.273.Peer-Reviewed Original ResearchOptimal antimicrobial therapyLength of stayGram-positive cocciBloodstream infectionsASP recommendationsHigher Charlson comorbidity indexMedian LOSCharlson Comorbidity IndexPost-implementation cohortPre-implementation cohortPrimary study endpointRetrospective chart reviewRapid diagnosticsPositive Gram stainYears of ageAntimicrobial stewardship effortsASP interventionsComorbidity indexPrimary endpointBaseline demographicsChart reviewSecondary outcomesStudy endpointPolymicrobial infectionsAntimicrobial therapy535. Evaluation of the BioFire Blood Culture Identification (BCID2) panel for transplant recipients with a bloodstream infection
Palacios C, Peaper D, Malinis M, Malinis M, Perreault S, Cohen E, Vogel J, Azar M. 535. Evaluation of the BioFire Blood Culture Identification (BCID2) panel for transplant recipients with a bloodstream infection. Open Forum Infectious Diseases 2022, 9: ofac492.588. PMCID: PMC9752191, DOI: 10.1093/ofid/ofac492.588.Peer-Reviewed Original ResearchBone marrow transplant recipientsTransplant recipientsBloodstream infectionsBlood culturesPositive blood culturesClinical trialsPrimary investigatorSolid organ recipientsMarrow transplant recipientsRetrospective chart reviewYear of transplantationAntimicrobial susceptibility resultsBlood Culture Identification PanelBSI eventsChart reviewOptimal therapyOrgan recipientsMean ageMultiplex PCR panelSame patientGeneral populationPolymicrobial culturesCandida sppPeripheral sitesRecipients
2020
Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients
Gaston DC, Malinis M, Osborn R, Peaper DR, Landry M, Juthani-Mehta M, Azar MM. Clinical implications of SARS-CoV-2 cycle threshold values in solid organ transplant recipients. American Journal Of Transplantation 2020, 21: 1304-1311. PMID: 33043603, PMCID: PMC7675520, DOI: 10.1111/ajt.16357.Peer-Reviewed Original ResearchConceptsSolid organ transplant recipientsOrgan transplant recipientsClinical implicationsCycle threshold valuesSOT patientsTransplant recipientsSymptom onsetYale New Haven Health SystemUpper respiratory tract samplesSARS-CoV-2 viral RNASARS-CoV-2 viral dynamicsAdult SOT recipientsRetrospective chart reviewRespiratory tract samplesSARS-CoV-2 cycle threshold valuesInfection prevention measuresCOVID-19 severityViral RNAHigher clinical acuityPrimary diagnostic testRT-PCR assaysSOT recipientsChart reviewViral loadAdmission severityOutcomes of Patients With Hospital-Acquired Influenza
Campbell M, James A, Fairweather I, Rivera-Vinas J, Kaslow R, Landry M, Peaper D, Martinello R. Outcomes of Patients With Hospital-Acquired Influenza. Infection Control And Hospital Epidemiology 2020, 41: s340-s340. DOI: 10.1017/ice.2020.951.Peer-Reviewed Original ResearchEscalation of careIntensive care unitCare unitLaboratory-proven influenzaOutcomes of patientsRetrospective cohort studyCommunity-based populationPediatric teaching hospitalLength of stayOnset of signsDiagnosis of pneumoniaMedical record informationDirect fluorescent antibodyNoninvasive ventilationChart reviewCohort studyInpatient morbidityMedian durationPatient demographicsAntiviral treatmentClinical courseRadiographic evidenceAntiviral administrationInfluenza infectionSupplemental oxygen